IR@PKUHSC  > 北京大学第一临床医学院  > 病理科
学科主题临床医学
Immunohistochemical detection of mutations in the epidermal growth factor receptor gene in lung adenocarcinomas using mutation-specific antibodies
Xiong, Yan1; Bai, Yun1; Leong, Nufatt2; Laughlin, Todd S.2; Rothberg, Paul G.2; Xu, Haodong2; Nong, Lin1; Zhao, Jing1; Dong, Ying1; Li, Ting1
关键词Lung adenocarcinoma Epidermal growth factor receptor Mutation Immunohistochemistry
刊名DIAGNOSTIC PATHOLOGY
2013-02-18
DOI10.1186/1746-1596-8-27
8
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Pathology
研究领域[WOS]Pathology
关键词[WOS]EGFR MUTATIONS ; PERSONALIZED MEDICINE ; CANCER
英文摘要

Background: The recent development of antibodies specific for the major hotspot mutations in the epidermal growth factor receptor (EGFR), L858R and E746_A750del, may provide an opportunity to use immunohistochemistry (IHC) as a screening test for EGFR gene mutations. This study was designed to optimize the IHC protocol and the criteria for interpretation of the results using DNA sequencing as the gold-standard.

Methods: Tumor sections from fifty lung adenocarcinoma specimens from Chinese patients were immunostained using L858R and E746_A750del-specific antibodies using three different antigen retrieval solutions, and the results were evaluated using three different sets of criteria. The same specimens were used for DNA purification and analysis of EGFR gene mutations.

Results: In this study the optimal buffer for antigen retrieval was EDTA (pH 8.0), and the optimal scoring method was to call positive results when there was moderate to strong staining of membrane and/or cytoplasm in >10% of the tumor cells. Using the optimized protocol, L858R-specific IHC showed a sensitivity of 81% and a specificity of 97%, and E746_A750del-specific IHC showed a sensitivity of 59% and a specificity of 100%, both compared with direct DNA analysis. Additionally, the mutant proteins as assessed by IHC showed a more homogeneous than heterogeneous pattern of expression.

Conclusions: Our data demonstrate that mutation-specific IHC, using optimized procedures, is a reliable prescreening test for detecting EGFR mutations in lung adenocarcinoma.

语种英语
WOS记录号WOS:000318244600001
引用统计
被引频次:21[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/61907
专题北京大学第一临床医学院_病理科
作者单位1.Peking Univ, Hosp 1, Dept Pathol, Beijing 100034, Peoples R China
2.Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA
推荐引用方式
GB/T 7714
Xiong, Yan,Bai, Yun,Leong, Nufatt,et al. Immunohistochemical detection of mutations in the epidermal growth factor receptor gene in lung adenocarcinomas using mutation-specific antibodies[J]. DIAGNOSTIC PATHOLOGY,2013,8.
APA Xiong, Yan.,Bai, Yun.,Leong, Nufatt.,Laughlin, Todd S..,Rothberg, Paul G..,...&Li, Ting.(2013).Immunohistochemical detection of mutations in the epidermal growth factor receptor gene in lung adenocarcinomas using mutation-specific antibodies.DIAGNOSTIC PATHOLOGY,8.
MLA Xiong, Yan,et al."Immunohistochemical detection of mutations in the epidermal growth factor receptor gene in lung adenocarcinomas using mutation-specific antibodies".DIAGNOSTIC PATHOLOGY 8(2013).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Xiong, Yan]的文章
[Bai, Yun]的文章
[Leong, Nufatt]的文章
百度学术
百度学术中相似的文章
[Xiong, Yan]的文章
[Bai, Yun]的文章
[Leong, Nufatt]的文章
必应学术
必应学术中相似的文章
[Xiong, Yan]的文章
[Bai, Yun]的文章
[Leong, Nufatt]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。